In mouse models for the Cardio-Velo-Facial/Di George syndrome, defects in the development of second heart field derivatives, such as the outflow tract, arise from altered Tbx1 dosage, including overexpression [47],[48]. The gene discussed is TBX1; the disease is 22q11.2 deletion syndrome.